Jump Financial, LLC

Position in NVAX — Novavax Inc

CIK 1831577 Chicago, IL

Position in NVAX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,929,357

+$1,755,975 QoQ

Shares Held

204,815

+861.6% QoQ

Ownership

0.124%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#46

of 263 holders

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Jump Financial, LLC holds $441,487,523 across 168 Biotechnology names. NVAX ranks #65 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	306,330	$24,288,904
2	VKTX	Viking Therapeutics, Inc.	579,882	$22,621,196
3	XENE	Xenon Pharmaceuticals Inc.	260,730	$15,737,662
4	CRSP	CRISPR Therapeutics AG	277,952	$15,159,500
5	BMRN	Biomarin Pharmaceutical Inc	245,390	$14,041,214
6	SRPT	Sarepta Therapeutics, Inc.	679,445	$12,209,626
7	REGN	Regeneron Pharmaceuticals, Inc.	16,242	$10,127,536
8	RARE	Ultragenyx Pharmaceutical Inc.	286,952	$9,581,327

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,929,357	204,815	+861.6%	Shares	Defined	2026-08-13
2026-03-31	$173,382	21,300	-95.4%	Shares	Defined	2026-05-14
2025-12-31	$3,138,925	467,102	+4.5%	Shares	Defined	2026-02-17
2025-09-30	$3,873,756	446,800	-12.7%	Shares	Defined	2026-08-13
2025-03-31	$3,280,266	511,742	-14.4%	Shares	Defined	2026-08-13
2024-09-30	$7,552,967	598,018	+97.7%	Shares	Defined	2024-11-14
2023-09-30	$2,189,903	302,473	+25.4%	Shares	Sole	2024-10-21
2023-06-30	$1,792,108	241,199	-41.3%	Shares	Sole	2024-10-21
2023-03-31	$2,847,633	410,914	+445.3%	Shares	Sole	2024-10-21
2022-06-30	$3,875,558	75,356	+4332.7%	Shares	Sole	2022-08-09
2021-12-31	$243,219	1,700	-83.6%	Shares	Sole	2022-02-10
2020-09-30	$1,123,806	10,372	—	Shares	Sole	2020-11-13
No filing history on record for this holder in this stock.